HSBC Research published a research report, listing the latest investment ratings and target prices for pharmaceutical and biotechnology stocks as follows:

Stock | Investment Rating | Target Price

BeiGene (ONC.US) | Buy | USD 323 -> USD 375

Innovent Biologics (01801.HK) | Buy | HKD 110 -> HKD 115

Kintor Pharmaceutical (06990.HK) | Buy | HKD 354 -> HKD 549

China National Pharmaceutical Group (01177.HK) | Buy | HKD 8.49 -> HKD 9.6

CSPC Pharma (01093.HK) | Buy | HKD 10.7 -> HKD 10.5

Hengrui Pharma (600276.SH) | Buy | RMB 73 -> RMB 79

Fosun Pharma (02196.HK) | Hold | HKD 17.2 -> HKD 26.5

LIVZON PHARMA (01513.HK) | Hold | HKD 37.54 -> HKD 37.23

HANSOH PHARMA (03692.HK) | Buy | HKD 47